ShareCompartir
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: [email protected]. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Notes from the Field: Strongyloides Infection Among Patients at a Long-Term Care Facility — Florida, 2010–2012
During a 2-week period in August 2011, two patients in a long-term care facility in Miami-Dade County, Florida, had gastrointestinal symptoms; microscopic examination of stool specimens showed that both harbored Strongyloides stercoralis, an intestinal nematode. A subsequent chart review revealed an additional case within the facility 1 year earlier. Concerned about the possibility of an outbreak, the associate director of patient care services at the facility contacted the Florida Department of Health in Miami-Dade County and the Florida State Department of Health, which contacted CDC. This report describes the subsequent investigation.
In May 2012, a serologic and risk-factor survey of residents and staff was performed to assess the prevalence of and associations with infection. Strongyloides informational packets were distributed to all residents and staff members, and consent for serologic testing was obtained. In June, blood samples from consenting residents and staff members were tested for S. stercoralis–specific antibody testing by crude antigen enzyme-linked immunosorbent assay. This serologic test becomes positive after infection (how long after infection is not well defined), and antibody titers typically drop to <50% by 6–18 months after successful treatment of the parasite.
In a convenience sample of 106 of the 176 facility residents, 12 (11%) had a positive result, as did three from a convenience sample of 26 of the 238 staff members. All 15 persons with positive results reported being born either in North America (five) or the West Indies (10). Thirty-seven long-term care facility residents in the convenience sample were born in the United States or Mexico, and four (10.8%) had results positive for S. stercoralis-specific antibody; only one of these persons reported no travel outside of the United States. Six long-term care facility residents reported corticosteroid use in the last 3 months, and none were infected. Because no prior testing had been performed, assessing whether any of the infections had been acquired within the facility was not possible.
Recommendations were made to offer testing and treatment to the residents and staff members who had not yet been approached and to extend this offer to incoming residents. Further research is needed to determine the prevalence of Strongyloides infection and the risk for transmission to help inform screening strategies for long-term care facilities.
Reported by
Andrea Leapley, Florida International Univ, Miami; Alazandria Cruze, MPH, Alvaro Mejia-Echeverry, MD, Florida Dept of Health Miami-Dade County, Danielle Stanek, DVM, Bureau of Disease Control and Prevention, Elesi Quaye, Bureau of Public Health Laboratories-Miami, Florida Dept of Health. Stephany Vento, Div of State and Local Readiness, Office of Public Health Preparedness and Response; Isabel McAuliffe, Susan P. Montgomery, DVM, Aaron M. Samuels, MD, Div of Parasitic Diseases and Malaria, Center for Global Health, CDC. Corresponding contributor: Aaron M. Samuels, [email protected], 404-718-4779.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All MMWR HTML versions of articles are electronic conversions from typeset documents.
This conversion might result in character translation or format errors in the HTML version.
Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr)
and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S.
Government Printing Office (GPO), Washington, DC 20402-9371;
telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
[email protected].
